Humacyte (NASDAQ:HUMA – Get Rating) issued its quarterly earnings results on Tuesday. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.20) by $0.61, MarketWatch Earnings reports. NASDAQ:HUMA opened at $7.06 on Friday. The business has a 50 day moving average price of $5.76 and a […]
Humacyte (NASDAQ:HUMA – Get Rating) had its target price decreased by equities researchers at Piper Sandler from $17.00 to $10.00 in a research note issued on Tuesday, The Fly reports. Piper Sandler’s price target suggests a potential upside of 37.55% from the stock’s previous close. Separately, Zacks Investment Research upgraded Humacyte from a “hold” rating […]
Wall Street analysts expect Humacyte, Inc. (NASDAQ:HUMA – Get Rating) to announce ($0.19) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Humacyte’s earnings. The firm is expected to issue its next earnings results before the market opens on Monday, January 1st. On average, analysts expect […]
Wall Street analysts predict that Humacyte, Inc. (NASDAQ:HUMA – Get Rating) will post sales of $260,000.00 for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Humacyte’s earnings, with the lowest sales estimate coming in at $120,000.00 and the highest estimate coming in at $400,000.00. The firm is scheduled to issue […]
Alpha Healthcare Acquisition Corp III (NASDAQ:ALPA – Get Rating) was the recipient of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 3,100 shares, a decline of 22.5% from the February 13th total of 4,000 shares. Approximately 0.0% of the company’s shares are short […]